Filing Details
- Accession Number:
- 0001062993-22-018157
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-17 07:19:19
- Reporting Period:
- 2022-08-15
- Accepted Time:
- 2022-08-17 07:19:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 10795 | Becton Dickinson & Co | BDX | Surgical & Medical Instruments & Apparatus (3841) | 220760120 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1621793 | Jr E Thomas Polen | C/O Becton, Dickinson And Company 1 Becton Drive Franklin Lakes NJ 07417 | Chairman, Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-15 | 15,000 | $167.91 | 43,878 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-15 | 5,500 | $265.13 | 38,378 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2022-08-15 | 9,500 | $265.13 | 28,878 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2022-08-15 | 15,000 | $0.00 | 15,000 | $167.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,184 | 2017-11-26 | 2026-11-26 | No | 4 | M | Direct |
Footnotes
- The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $263.79 through $265.64. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on May 12, 2022.
- Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.
- Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.
- The stock appreciation rights vest in four annual installments beginning November 26, 2017.
Billionaire Hedge Funds
